IMS Health — Q1 2014 Earnings Presentation
30 slides from IMS Health's earnings presentation, May 1, 2014
Slide 1: IMS Health Q1 2014 Earnings Call
IMS Health Q1 2014 Earnings Call May 1, 2014 IMS Health Confidential. (c) 2014 IMS Health Incorporated. All Rights Reserved.
Slide 2: Legal
Legal This presentation should be viewed in conjunction with IMS Health’s Q1 2014 earnings call Safe Harbor Statement This presentation includes “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation g Reform Act of 1995, including g statements
Slide 3: Financial Performance
Financial Performance $M, 2010 - 2013 Revenue EBITDA 6% CAGR 11% CAGR @ CFx @ CFx $2,544 $829 $2,162 $620 2010 2013 2010 2013 Dollars are actual foreign exchange rates. EBITDA is “Adjusted EBITDA” as defined in the IMS Health financial statements. CFx is constant currency. IMS Health Confidential. D
Slide 4: Margins
Margins Rolling 4Qs SG&A % Revenue EBITDA % Revenue 33% 31% 29% 27% 25% 23% 21% 2010 2011 2012 2013 SG&A expense includes: Sales, Sales marketing marketing, administration, administration IT & infrastructure & non capitalized software development. development Revenue does not reflect deferred revenu
Slide 5: Operational Transformation
Operational Transformation 9,500 7,100 5,200 7,600 Exits Hires 2010 • Delayering • Global COEs Dec. 2013 • Skills upgrade • Technology skills • Process automation • Acquisitions • Customer facing • Emerging markets IMS Health Confidential. Do not distribute outside your organization. 5 (c) 2014 IMS
Slide 6: Growth Strategy: Offerings
Growth Strategy $M, 2010 – 2013 Revenue Offerings CAGR $2,544 $2,162 +13% $1,019 @ CFx Technology Services $714 +2% Information $1,448 @ CFx $1,525 2010 2013 Dollars are actual foreign exchange rates. CFx is constant currency. IMS Health Confidential. Do not distribute outside your organization. 6 (
Slide 7: Growth Strategy: Geography
Growth Strategy $M, 2010 – 2013 Revenue Geography CAGR $2,544 $2,162 $440 +11% Emerging Markets $331 @ CFx +5% Developed Markets $1,831 @ CFx $2,104 2010 2013 Dollars are actual foreign exchange rates. CFx is constant currency. IMS Health Confidential. Do not distribute outside your organization. 7
Slide 8: 1st Quarter Results
1st Quarter Results $M Revenue EBITDA +6.6% +9.5% @ CFx @ CFx $645 $613 $217 $203 Q1 2013 Q1 2014 Q1 2013 Q1 2014 Dollars are actual foreign exchange rates. EBITDA is “Adjusted EBITDA” as defined in the IMS Health financial statements. CFx is constant currency. IMS Health Confidential. Do not distri
Slide 9: 1st Quarter Revenue by Offering
1st Quarter Revenue Offering 1st Quarter Versus Prior Year Constant $M 2014 2013 Reported Currency I f Information i $382 $378 1 0% 1.0% 2 8% 2.8% Technology $263 $235 11.9% 12.5% Services T t l Total $645 $613 5 2% 5.2% 6 6% 6.6% IMS Health Confidential. Do not distribute outside your organization.
Slide 10: 1st Quarter Revenue by Geography
1st Quarter Revenue Geography 1st Quarter Versus Prior Year Constant $M 2014 2013 Reported Currency D Developed l d Markets M k t $532 $511 4 2% 4.2% 5 0% 5.0% Emerging Markets $113 $102 10.4% 14.7% T t l Total $645 $613 5 2% 5.2% 6 6% 6.6% IMS Health Confidential. Do not distribute outside your org
Slide 11: 1st Quarter EBITDA
1st Quarter EBITDA 1st Quarter Versus Prior Year Constant $M 2014 2013 Reported Currency Adjusted EBITDA $217 $203 7.2% 9.5% Adjusted EBITDA 33.7% 33.1% 60 bps 90 bps margin IMS Health Confidential. Do not distribute outside your organization. 11 (c) 2014 IMS Health Incorporated. All Rights Reserved
Slide 12: 1st Quarter P&L
1st Quarter P&L $M (except per share data) 2014 2013 Operating Income $67 $79 Net (Loss) / Income $(24) $12 Adjusted Net Income $70 $76 Diluted (Loss) / Earnings per Share $(0.09) $0.04 Diluted Adjusted EPS $0 24 $0.24 $0 26 $0.26 IMS Health Confidential. Do not distribute outside your organization.
Slide 13: 1st Quarter Balance Sheet Items & Metrics
1st Quarter Balance Sheet Items & Metrics $M 2014 2013 Cash & Cash Equivalents & Short Term $544 $729 1 Investments G Gross D Debt bt 2 $5 027 $5,027 $5,027 $5 027 1 Net Debt $4,483 $4,298 1 Cash Used in Operating Activities $(103) $(16) Unlevered Free Cash Flow $(11) $57 Capital Expenditures $(54)
Slide 14: IPO Summary
IPO Summary • April 4th IMS Health stock (IMS) started trading on the NYSE • 65 million offered at $20.00 per share • 52 million primary shares sold by IMS Health • 13 million secondary shares sold by selling shareholders • 9.75 million additional secondary shares purchased by underwriters (15% unde
Slide 15: IPO Proceeds - Estimated Sources and Uses
IPO Proceeds - Estimated Sources and Uses $M SOURCES USES IPO Proceeds 1,040 Retire 12.5% Senior Notes 1,136 Term Loan A 500 Retire 7.375 Senior PIK Notes 765 Cash 400 IPO & Debt Fees 1 82 Revolver 148 Other 2 105 Total Sources 2,088 Total Uses 2,088 1. $24M paid in Q1. 2. Other includes: $72M one-t
Slide 16: IPO Pro Forma Gross Leverage Ratio
IPO Pro Forma Gross Leverage Ratio $M * Gross debt excludes unamortized OID. IMS Health Confidential. Do not distribute outside your organization. 16 (c) 2014 IMS Health Incorporated. All Rights Reserved.
Slide 17: Interest Expense Reduction
Interest Expense Pro forma annualized - $M 356 ~50% Reduction 169 PRE-IPO POST-IPO* Non Cash Cash * Post-IPO interest expense is based on the pro forma capitalization on the prior slide. IMS Health Confidential. Do not distribute outside your organization. 17 (c) 2014 IMS Health Incorporated. All Ri
Slide 18: Pro Forma Debt Maturity
Pro Forma Debt Maturity $M 3,000 2,500 Term Loan 2 000 2,000 B EUR 1,500 Term 1,000 Loan B Revolver USD 500 6% --Term Loan A & Term Loan B Amortization-- Term Notes Loan A 0 2014 2015 2016 2017 2018 2019 2020 2021 IMS Health Confidential. Do not distribute outside your organization. 18 (c) 2014 IMS
Slide 19: 2014 Full-Year Guidance
2014 Full-Year Guidance 2014 VPY% Revenue 5 - 6% Adjusted EBITDA 7.5 - 9.0% Adjusted Net Income 15 – 20% Unlevered FCF/Adj. EBITDA * 80% * Excludes India Building Purchase IMS Health Confidential. Do not distribute outside your organization. 19 (c) 2014 IMS Health Incorporated. All Rights Reserved.
Slide 20: Q&A
Q&A IMS Health Confidential. (c) 2014 IMS Health Incorporated. All Rights Reserved.
Slide 21: Appendix: Non-GAAP Financial Measures
Appendix: Non-GAAP Financial Measures IMS Health Confidential. (c) 2014 IMS Health Incorporated. All Rights Reserved.
Slide 22: Net Income to Adjusted EBITDA
Net Income to Adjusted EBITDA 1st Quarter 1st Quarter $M 2014 2013 Net (Loss) Income $(24) $12 (Benefit from) provision for income taxes (13) 5 Other loss (income), net * 17 (16) Interest expense 89 79 Interest income (2) (1) Depreciation and amortization 107 105 Deferred revenue purchase accounting
Slide 23: Net Income to Adjusted EBITDA
Net Income to Adjusted EBITDA 2009 -2010 2009 2010 $M F ll Year Full Y Q1 Q2 Q3 Q4 F ll Year Full Y Net (Loss) Income $260 $(106) $22 $(78) $(41) $(202) (Benefit from) provision for (24) (56) 13 (68) (2) (113) income taxes Other loss (income), net * 1 71 (77) 98 (48) 44 Interest expense 36 30 75 77
Slide 24: Net Income to Adjusted EBITDA
Net Income to Adjusted EBITDA 2011 2011 $M Q1 Q2 Q3 Q4 Full Year Net (Loss) Income $(64) $(32) $43 $164 $111 (Benefit from) provision for income (18) (26) 13 (142) (173) taxes Other loss (income), net * 66 32 (48) (42) 7 Interest expense 65 73 73 65 276 Interest income - - (1) - (2) Depreciation and
Slide 25: Net Income to Adjusted EBITDA
Net Income to Adjusted EBITDA 2012 2012 $M Q1 Q2 Q3 Q4 Full Year Net (Loss) Income $28 $(21) $4 $(53) $(42) (Benefit from) provision for income (64) 74 (37) 7 (19) taxes Other loss (income), net * 31 (74) 36 35 29 Interest expense 68 64 64 79 275 Interest income - - (1) (2) (3) Depreciation and amor
Slide 26: Net Income to Adjusted EBITDA
Net Income to Adjusted EBITDA 2013 2013 $M Q1 Q2 Q3 Q4 Full Year Net (Loss) Income $12 $8 $(20) $82 $82 (Benefit from) provision for income 5 9 (20) (124) (130) taxes Other loss (income), net * (16) 6 54 30 74 Interest expense 79 75 87 92 333 Interest income (1) (2) (1) (2) (5) Depreciation and amor
Slide 27: Net Income to Adjusted Net Income & Per Share Data
Net Income to Adjusted Net Income & Per Share Data 1st Quarter $M (except per share data) 2014 2013 Net (Loss) Income $(24) $12 ((Benefit from)) p provision for income taxes ((13)) 5 Amortization associated with purchase accounting 76 75 Deferred revenue purchase accounting adjustments 2 1 Non-cash
Slide 28: Gross Leverage Ratio
Gross Leverage Ratio 1st Quarter 1st Quarter $M as of March 31, 2014 Gross Debt as of March 31, 2014 $5,027 Adjusted EBITDA for the year ended December 31, 2013(1) 829 Less: Adjusted EBITDA for the three months ended March 31, 2013 (203) Add: Adjusted EBITDA for the three months ended March 31, 2014
Slide 29: Unlevered Free Cash Flow Reconciliation
Unlevered Free Cash Flow Reconciliation 1st Quarter 1st Quarter $M 2014 2013 Net Cash Used by Operating Activities $(103) $(16) Capital expenditures (33) (7) Additions to computer software (21) (14) Free Cash Flow $(157) $(37) Cash interest payments 102 67 Cash tax payments 29 19 Acquisition related
Slide 30: END
END IMS Health Confidential. Do not distribute outside your organization. 30 (c) 2014 IMS Health Incorporated. All Rights Reserved.